Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oncology APIs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101307040B details a novel NBS derivatization method for separating Paclitaxel from Cephalomannine, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN1222523A details a novel route for 9-amino camptothecin, recycling 12-nitro byproducts to ensure cost reduction in pharmaceutical manufacturing and high purity.
Novel Cu-catalyzed route for Flumatinib intermediate CN111763170A. Eliminates genotoxic impurities, reduces cost, ensures supply continuity for API manufacturing.
Patent CN111377989B reveals a high-selectivity synthesis for decitabine intermediates, offering superior beta-isomer ratios and scalable purification for cost-effective API manufacturing.
Patent CN111763209B details a novel Ruxolitinib synthesis avoiding expensive catalysts. Discover cost reduction in API manufacturing and high-purity pharmaceutical intermediates.
Patent CN111032650A details a safer, scalable route for EGFR inhibitor intermediates, eliminating hazardous sodium hydride and iron reduction for cost-effective manufacturing.
Discover a novel N-to-C synthesis route for Carfilzomib avoiding racemization. High yield, chromatography-free purification for cost-effective API manufacturing.
Patent CN106854200A details a high-yield Ceritinib synthesis route eliminating Boc protection steps, ensuring high-purity pharmaceutical intermediates and supply chain reliability.
Patent CN1033589C details a scalable synthesis of etoposide phosphate using haloacetyl protection, offering superior purity and cost reduction in pharmaceutical intermediate manufacturing.
Novel silanization route for Decitabine intermediates offering high purity and industrial scalability without column chromatography.
Patent CN114380748A details a continuous flow synthesis for Pazopanib intermediates, offering enhanced safety, purity, and scalable manufacturing capabilities for global supply chains.
Advanced synthesis of Cyclophosphamide via patent CN109535201B. Offers high yield, mild conditions, and cost reduction in API manufacturing for reliable pharmaceutical intermediates supplier partnerships.
Patent CN101792416A details a cost-effective Bosutinib synthesis using vanillic acid, offering mild conditions and high purity for reliable pharmaceutical intermediate supply chains.
Novel 4-step route for Tomivosertib offers high purity and simplified processing for cost-effective API manufacturing and supply chain stability.
Patent CN101016293A details a catalyst-free route for imatinib intermediates, offering significant cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.
Patent CN1761644A details scalable synthesis of 4-amino-2-butenoyl chloride for kinase inhibitors. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN107653273B reveals a dual-enzyme one-pot method for high-yield benzoquinone synthesis, offering green manufacturing and cost reduction for pharmaceutical intermediates.
Patent CN109369638B details a green, high-yield synthesis of dasatinib intermediates using heteropolyacid catalysis, offering significant cost reduction in API manufacturing.
Patent CN102675197A details a high-yield, eco-friendly route for Sorafenib intermediate. Reduces solvent use and improves purity for scalable manufacturing.
Patent CN1269819C reveals a safer synthetic route for temozolomide, eliminating hazardous reagents and improving yield for cost reduction in API manufacturing.